Koyfin Home > Directory > Health Care > Adma Biologics > Cost of Goods Sold

Adma Biologics Cost of Goods Sold Chart (ADMA)

Adma Biologics annual/quarterly Cost of Goods Sold from 2011 to 2020.
  • Adma Biologics Cost of Goods Sold for the quarter ending June 06, 2020 was $13m a 41.34% increase of 6m year over year
  • Adma Biologics Cost of Goods Sold for the last 12 months ending June 06, 2020 was $50m a 21.99% increase of 11m year over year
  • Adma Biologics Annual Cost of Goods Sold for 2019 was $40m a -6.81% decrease of -3m from 2018
  • Adma Biologics Annual Cost of Goods Sold for 2018 was $42m a 30.88% increase of 13m from 2017
  • Adma Biologics Annual Cost of Goods Sold for 2017 was $29m a 78.19% increase of 23m from 2016
Other Income Statement Metrics:
  • Adma Biologics EBITDA for the quarter ending December 12, 2018 was $-16m a -0.51% increase of 0m year over year
  • Adma Biologics Net Income for the quarter ending December 12, 2018 was $-18m a 1.20% decrease of 0m year over year
  • Adma Biologics Total Revenue for the quarter ending September 09, 2018 was $4m a -183.74% decrease of -8m year over year
View Chart On Koyfin

Quarterly ADMA Cost of Goods Sold Data

06/2020$13m
03/2020$17m
12/2019$12m
09/2019$8m
06/2019$10m
03/2019$9m
12/2018$11m
09/2018$9m
06/2018$10m
03/2018$12m

Annual ADMA Cost of Goods Sold Data

2019$40m
2018$42m
2017$29m
2016$6m
2015$4m
2014$4m
2013$2m
2012$1m
2011$0m